LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 135

Search options

  1. Article: Lupus autoantibodies 101: one size does not fit all; however, specificity influences pathogenicity.

    Madaio, M P

    Clinical and experimental immunology

    2003  Volume 131, Issue 3, Page(s) 396–397

    MeSH term(s) Animals ; Antibody Specificity ; Autoantibodies/immunology ; Disease Susceptibility/immunology ; Humans ; Lupus Erythematosus, Systemic/immunology ; Neutrophils/immunology
    Chemical Substances Autoantibodies
    Language English
    Publishing date 2003-03
    Publishing country England
    Document type Editorial
    ZDB-ID 218531-3
    ISSN 1365-2249 ; 0009-9104 ; 0964-2536
    ISSN (online) 1365-2249
    ISSN 0009-9104 ; 0964-2536
    DOI 10.1046/j.1365-2249.2003.02112.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Major peptide autoepitopes for nucleosome-specific T cells of human lupus.

    Madaio, M P

    American journal of kidney diseases : the official journal of the National Kidney Foundation

    2000  Volume 35, Issue 5, Page(s) 992–996

    MeSH term(s) Epitopes, T-Lymphocyte/immunology ; Humans ; Lupus Erythematosus, Systemic/immunology ; Nucleosomes/immunology
    Chemical Substances Epitopes, T-Lymphocyte ; Nucleosomes
    Language English
    Publishing date 2000-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604539-x
    ISSN 1523-6838 ; 0272-6386
    ISSN (online) 1523-6838
    ISSN 0272-6386
    DOI 10.1016/s0272-6386(00)70277-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: The role of autoantibodies in the pathogenesis of lupus nephritis.

    Madaio, M P

    Seminars in nephrology

    1999  Volume 19, Issue 1, Page(s) 48–56

    Abstract: Despite intensive research over the past three decades, the events leading to pathogenic autoantibody production and immune deposit formation in individuals with systemic lupus erythematosus continues to be debated. The controversy is fueled by the ... ...

    Abstract Despite intensive research over the past three decades, the events leading to pathogenic autoantibody production and immune deposit formation in individuals with systemic lupus erythematosus continues to be debated. The controversy is fueled by the clinical observations that individual patients with lupus have variable expression of disease, and that it is often difficult to completely distinguish the events involved in the initiation of nephritis from the processes leading to progressive disease and organ failure. This review focuses on the mechanisms of immune deposition in individuals with lupus nephritis. Recent evidence derived from both analysis of spontaneously occurring animal models of lupus nephritis and human lupus nephritis suggests that direct binding of autoantibodies to glomerular antigens is an important mechanism in lupus and other immune complex nephritides. In situ deposition of circulating autoantigens and autoantibodies also may play a role. These findings, taken together with observations from analysis of other autoimmune diseases, suggest that autoantigen ligation by autoantibodies may contribute to the inflammatory/fibrogenic response through either direct stimulation of cells or interruption of cell-cell or cell matrix interactions. The nature of these type of interactions in individual patients therefore may have disease-modulating effects. For example, the predominant autoantibody response likely influences the glomerular response to immune deposition and the ensuing inflammation. The evidence for, and implications of, this hypothesis are discussed.
    MeSH term(s) Animals ; Antibody Specificity ; Antigen-Antibody Complex/immunology ; Antigens, Surface/immunology ; Autoantibodies/immunology ; Autoimmunity/immunology ; Binding Sites ; Humans ; Lupus Nephritis/immunology
    Chemical Substances Antigen-Antibody Complex ; Antigens, Surface ; Autoantibodies
    Language English
    Publishing date 1999-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 604652-6
    ISSN 1558-4488 ; 0270-9295
    ISSN (online) 1558-4488
    ISSN 0270-9295
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: B cells and autoantibodies in the pathogenesis of lupus nephritis.

    Madaio, M P

    Immunologic research

    1998  Volume 17, Issue 1-2, Page(s) 123–132

    Abstract: Although autoantibodies and autoantibody-producing B cells are crucial for the initiation of lupus nephritis, their precise role in the development of the nephritic lesions is incompletely understood. This article summarizes the results of recent work in ...

    Abstract Although autoantibodies and autoantibody-producing B cells are crucial for the initiation of lupus nephritis, their precise role in the development of the nephritic lesions is incompletely understood. This article summarizes the results of recent work in our laboratory related to this area. They indicate that not all autoantibodies are pathogenic. Furthermore, among the pathogenic subset, individual immunoglobulins produce clearly distinguishable immune deposit patterns in specific glomerular locations and this is associated with different disease profiles (i.e., inflammation, proteinuria). The variation in immune deposit formation induced by the individual autoantibodies are reminiscent of the different lesions in lupus patients, and they appear to be related to differences in the reactivity of autoantibodies with specific glomerular antigens. Thus, it appears that the predominant interaction in a given individual influences the morphologic and clinical expression of disease. Autoantibody-producing B cells also influence the activation of autoreactive T cells that infiltrate the kidney to produce vasculitis and interstitial nephritis, and the potential mechanisms responsible for this phenomenon are discussed.
    MeSH term(s) Animals ; Autoantibodies/immunology ; B-Lymphocytes/immunology ; Humans ; Lupus Nephritis/immunology ; Lymphocyte Cooperation ; T-Lymphocytes/immunology
    Chemical Substances Autoantibodies
    Language English
    Publishing date 1998
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 632857-x
    ISSN 1559-0755 ; 0257-277X
    ISSN (online) 1559-0755
    ISSN 0257-277X
    DOI 10.1007/BF02786437
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Diagnosis and treatment of nephrotic syndrome.

    Verma, S P / Madaio, M P

    Expert opinion on investigational drugs

    2005  Volume 8, Issue 6, Page(s) 787–796

    Abstract: Prompt diagnosis is essential in the planning of effective treatment for the underlying diseases responsible for nephrotic syndrome. In this review, the typical clinical and laboratory features that facilitate diagnosis of these disorders are discussed. ... ...

    Abstract Prompt diagnosis is essential in the planning of effective treatment for the underlying diseases responsible for nephrotic syndrome. In this review, the typical clinical and laboratory features that facilitate diagnosis of these disorders are discussed. The distinction between systemic diseases, involving the kidney, and primary glomerular diseases is emphasised. These clinical and pathological distinctions influence prognosis, and form the basis of therapy to treat the underlying disorders. Our discussion focuses on diagnosis and specific treatment of these diseases, as well as therapy of the clinical consequences of nephrotic syndrome per se.
    Language English
    Publishing date 2005-06-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 1182884-5
    ISSN 1744-7658 ; 0967-8298 ; 1354-3784
    ISSN (online) 1744-7658
    ISSN 0967-8298 ; 1354-3784
    DOI 10.1517/13543784.8.6.787
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Pathogenic autoantibodies in lupus nephritis.

    Waldman, M / Madaio, M P

    Lupus

    2005  Volume 14, Issue 1, Page(s) 19–24

    Abstract: Lupus nephritis is a major complication of systemic lupus erythematosus (SLE) and is associated with a high rate of morbidity and mortality. While many different immunologic and nonimmunologic factors contribute to disease expression in lupus nephritis, ... ...

    Abstract Lupus nephritis is a major complication of systemic lupus erythematosus (SLE) and is associated with a high rate of morbidity and mortality. While many different immunologic and nonimmunologic factors contribute to disease expression in lupus nephritis, a large body of evidence suggests that the production of anti-DNA antibodies and the formation of glomerular immune deposits are important initial events in the pathogenesis of the disease. This review will summarize our current understanding of the differences between pathogenic and nonpathogenic autoantibodies, the mechanisms by which these autoantibodies induce renal injury and the effector mechanisms which are subsequently activated by the deposited autoantibodies that ultimately lead to the expression of the different lupus lesions.
    MeSH term(s) Antibodies, Antinuclear/immunology ; Autoantibodies/immunology ; Humans ; Lupus Nephritis/immunology ; Lupus Nephritis/physiopathology
    Chemical Substances Antibodies, Antinuclear ; Autoantibodies
    Language English
    Publishing date 2005
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 1154407-7
    ISSN 0961-2033
    ISSN 0961-2033
    DOI 10.1191/0961203305lu2054oa
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: SARS-CoV-2 Reinfection in a Liver Transplant Recipient.

    Tomkins-Tinch, Christopher H / Daly, Jennifer S / Gladden-Young, Adrianne / Theodoropoulos, Nicole M / Madaio, Michael P / Yu, Neng / Vanguri, Vijay K / Siddle, Katherine J / Adams, Gordon / Krasilnikova, Lydia A / Movahedi, Babak / Bozorgzadeh, Adel / Simin, Karl / Lemieux, Jacob E / Luban, Jeremy / Park, Daniel J / MacInnis, Bronwyn L / Sabeti, Pardis C / Levitz, Stuart M

    Annals of internal medicine

    2021  Volume 174, Issue 8, Page(s) 1178–1180

    MeSH term(s) COVID-19/diagnosis ; COVID-19/virology ; COVID-19 Nucleic Acid Testing ; Humans ; Immunocompromised Host ; Immunosuppressive Agents ; Liver Transplantation ; Male ; Middle Aged ; Mycophenolic Acid/therapeutic use ; Phylogeny ; Reinfection ; SARS-CoV-2/genetics ; Tacrolimus/therapeutic use
    Chemical Substances Immunosuppressive Agents ; Mycophenolic Acid (HU9DX48N0T) ; Tacrolimus (WM0HAQ4WNM)
    Language English
    Publishing date 2021-04-20
    Publishing country United States
    Document type Case Reports ; Letter ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 336-0
    ISSN 1539-3704 ; 0003-4819
    ISSN (online) 1539-3704
    ISSN 0003-4819
    DOI 10.7326/L21-0108
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Human anti-α3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis.

    Kvirkvelia, Nino / McMenamin, Malgorzata / Gutierrez, Vanessa Iris / Lasareishvili, Besarion / Madaio, Michael P

    American journal of physiology. Renal physiology

    2015  Volume 309, Issue 8, Page(s) F680–4

    Abstract: Current therapies to limit kidney disease progression lack specificity and often have systemic toxicity. To approach this problem, we postulated that a human monoclonal antibody (F1.1), directed against the noncollagenous-1 domain (NC1) of α3(IV) ... ...

    Abstract Current therapies to limit kidney disease progression lack specificity and often have systemic toxicity. To approach this problem, we postulated that a human monoclonal antibody (F1.1), directed against the noncollagenous-1 domain (NC1) of α3(IV) collagen that localizes in glomeruli, could serve as a vehicle for targeted drug delivery. Given enhanced exposure of the NC1 domain of α3(IV) during glomerular diseases, with limited epitope expression in other organs, α3(IV)NC1 provides an ideal target for delivery of disease-modifying agents. As a potential disease-modifying agent, we initially took advantage of recent observations that PGE2 promoted recovery after established injury during the course of nephrotoxic nephritis. To address the general applicability of the approach, the efficacy of glomerular delivery of dexamethasone was also examined. To achieve glomerular targeted therapy, PGE2 and dexamethasone were coupled to F1.1. After confirmation of the composition and activity of the conjugates, both glomerular localization and the capacity of the conjugates to modify disease were evaluated. After injection into mice with established nephritis, resolution of disease was enhanced with both agents, with normalization of histology and improved blood urea nitrogen levels in conjugate-treated mice compared with untreated mice. The results provide a novel means of targeting glomeruli during nephritis, irrespective of cause, by providing efficient drug delivery, with the potential of limiting systemic effects.
    MeSH term(s) Animals ; Anti-Glomerular Basement Membrane Disease/chemically induced ; Anti-Glomerular Basement Membrane Disease/drug therapy ; Anti-Inflammatory Agents/therapeutic use ; Antibodies, Monoclonal/therapeutic use ; Autoantigens/immunology ; Blood Urea Nitrogen ; Cell Line ; Collagen Type IV/immunology ; Dexamethasone/analogs & derivatives ; Dexamethasone/therapeutic use ; Dinoprostone/analogs & derivatives ; Dinoprostone/therapeutic use ; Drug Delivery Systems ; Female ; Hepatocytes ; Humans ; Immunoconjugates/therapeutic use ; Kidney Glomerulus/drug effects ; Mice ; Mice, Inbred C57BL ; Nephritis/drug therapy ; Nephritis/immunology ; Podocytes/drug effects ; Sheep
    Chemical Substances Anti-Inflammatory Agents ; Antibodies, Monoclonal ; Autoantigens ; Collagen Type IV ; Immunoconjugates ; type IV collagen alpha3 chain ; Dexamethasone (7S5I7G3JQL) ; Dinoprostone (K7Q1JQR04M)
    Language English
    Publishing date 2015-10-15
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 603837-2
    ISSN 1522-1466 ; 0363-6127
    ISSN (online) 1522-1466
    ISSN 0363-6127
    DOI 10.1152/ajprenal.00289.2015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Best Practices for Physician-Scientist Training Programs: Recommendations from the Alliance for Academic Internal Medicine.

    Blanchard, Melvin / Burton, M Caroline / Geraci, Mark W / Madaio, Michael P / Marsh, James D / Proweller, Aaron / Rockey, Don C / Salata, Robert A / Tan, Winston / Williams, Christopher S / Zaidi, Mone / Todd, Robert F

    The American journal of medicine

    2018  Volume 131, Issue 5, Page(s) 578–584

    MeSH term(s) Biomedical Research/education ; Curriculum ; Education, Medical, Graduate/organization & administration ; Humans ; Internship and Residency ; Mentoring ; Research Support as Topic/statistics & numerical data ; United States
    Language English
    Publishing date 2018-02-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80015-6
    ISSN 1555-7162 ; 1873-2178 ; 0002-9343 ; 1548-2766
    ISSN (online) 1555-7162 ; 1873-2178
    ISSN 0002-9343 ; 1548-2766
    DOI 10.1016/j.amjmed.2018.01.015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Kidney-targeted inhibition of protein kinase C-α ameliorates nephrotoxic nephritis with restoration of mitochondrial dysfunction.

    Kvirkvelia, Nino / McMenamin, Malgorzata / Warren, Marie / Jadeja, Ravirajsinh N / Kodeboyina, Sai Karthik / Sharma, Ashok / Zhi, Wenbo / O'Connor, Paul M / Raju, Raghavan / Lucas, Rudolf / Madaio, Michael P

    Kidney international

    2018  Volume 94, Issue 2, Page(s) 280–291

    Abstract: To investigate the role of protein kinase C-α (PKC-α) in glomerulonephritis, the capacity of PKC-α inhibition to reverse the course of established nephrotoxic nephritis (NTN) was evaluated. Nephritis was induced by a single injection of nephrotoxic serum ...

    Abstract To investigate the role of protein kinase C-α (PKC-α) in glomerulonephritis, the capacity of PKC-α inhibition to reverse the course of established nephrotoxic nephritis (NTN) was evaluated. Nephritis was induced by a single injection of nephrotoxic serum and after its onset, a PKC-α inhibitor was administered either systemically or by targeted glomerular delivery. By day seven, all mice with NTN had severe nephritis, whereas mice that received PKC-α inhibitors in either form had minimal evidence of disease. To further understand the underlying mechanism, label-free shotgun proteomic analysis of the kidney cortexes were performed, using quantitative mass spectrometry. Ingenuity pathway analysis revealed 157 differentially expressed proteins and mitochondrial dysfunction as the most modulated pathway. Functional protein groups most affected by NTN were mitochondrial proteins associated with respiratory processes. These proteins were down-regulated in the mice with NTN, while their expression was restored with PKC-α inhibition. This suggests a role for proteins that regulate oxidative phosphorylation in recovery. In cultured glomerular endothelial cells, nephrotoxic serum caused a decrease in mitochondrial respiration and membrane potential, mitochondrial morphologic changes and an increase in glycolytic lactic acid production; all normalized by PKC-α inhibition. Thus, PKC-α has a critical role in NTN progression, and the results implicate mitochondrial processes through restoring oxidative phosphorylation, as an essential mechanism underlying recovery. Importantly, our study provides additional support for targeted therapy to glomeruli to reverse the course of progressive disease.
    MeSH term(s) Animals ; Antibodies, Monoclonal/immunology ; Autoantigens/immunology ; Collagen Type IV/immunology ; Disease Models, Animal ; Drug Delivery Systems/methods ; Female ; Glomerulonephritis/drug therapy ; Glomerulonephritis/immunology ; Glomerulonephritis/pathology ; Humans ; Hybridomas ; Immune Sera/administration & dosage ; Immune Sera/immunology ; Immunoglobulin Fragments/immunology ; Immunoglobulin G/immunology ; Kidney Glomerulus/drug effects ; Kidney Glomerulus/immunology ; Kidney Glomerulus/pathology ; Mice ; Mice, Inbred C57BL ; Mitochondria/drug effects ; Mitochondria/immunology ; Mitochondria/metabolism ; Oxidative Phosphorylation/drug effects ; Protein Kinase C-alpha/antagonists & inhibitors ; Protein Kinase C-alpha/immunology ; Protein Kinase C-alpha/metabolism ; Protein Kinase Inhibitors/immunology ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Treatment Outcome
    Chemical Substances Antibodies, Monoclonal ; Autoantigens ; Collagen Type IV ; Immune Sera ; Immunoglobulin Fragments ; Immunoglobulin G ; Protein Kinase Inhibitors ; type IV collagen alpha3 chain ; Prkca protein, mouse (EC 2.7.11.13) ; Protein Kinase C-alpha (EC 2.7.11.13)
    Language English
    Publishing date 2018-05-04
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 120573-0
    ISSN 1523-1755 ; 0085-2538
    ISSN (online) 1523-1755
    ISSN 0085-2538
    DOI 10.1016/j.kint.2018.01.032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top